Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Chemed Affirms FY2025 Adj EPS Guidance of $22.00-$22.30 vs $22.15 Est

Author: Benzinga Newsdesk | October 28, 2025 03:18pm
Chemed (NYSE:CHE) affirms FY2025 Adj EPS guidance from $22.00-$22.30 to $22.00-$22.30 vs $22.15 analyst estimate..

Posted In: CHE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist